UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
Bright Horizons
BFAM
$3.39B
| $12.6M | ﹤0.01% |
177,589
-332
| -0.2% | -$24K |
2014 Q1
49 quarters
|
|
1102
Axcelis
ACLS
$4.01B
| $12.5M | ﹤0.01% |
66,069
+1,519
| +2% | +$225K |
2023 Q1
13 quarters
|
|
1103
Chord Energy
CHRD
$7.86B
| $12.4M | ﹤0.01% |
108,728
-3,906
| -3% | -$530K |
2021 Q2
20 quarters
|
|
1104
Shell
SHEL
$289B
| $12.4M | ﹤0.01% |
160,073
-93
| -0.1% | -$8.03K |
2025 Q4
2 quarters
|
|
1105
Radian Group
RDN
$4.49B
| $12.4M | ﹤0.01% |
329,362
-729,751
| -69% | -$25.9M |
2013 Q2
52 quarters
|
|
1106
TPG
TPG
$7.55B
| $12.4M | ﹤0.01% |
305,465
-368
| -0.1% | -$15.5K |
2022 Q2
16 quarters
|
|
1107
Vanguard Total International Bond ETF
BNDX
$83.2B
| $12.4M | ﹤0.01% |
255,624
-43
| -0% | -$2.07K |
2025 Q4
2 quarters
|
|
1108
Pricesmart
PSMT
$5.24B
| $12.4M | ﹤0.01% |
63,326
-348
| -0.5% | -$58K |
2013 Q2
52 quarters
|
|
1109
Credit Acceptance
CACC
$5.68B
| $12.3M | ﹤0.01% |
19,393
+1,549
| +9% | +$829K |
2013 Q2
52 quarters
|
|
1110
Associated Banc-Corp
ASB
$5.45B
| $12.3M | ﹤0.01% |
400,453
+51,068
| +15% | +$1.44M |
2023 Q1
13 quarters
|
|
1111
Kodiak Gas Services
KGS
$5.27B
| $12.3M | ﹤0.01% |
163,851
-16,278
| -9% | -$1.11M |
2023 Q4
10 quarters
|
|
1112
ESAB
ESAB
$4.13B
| $12.3M | ﹤0.01% |
124,793
-1,613
| -1% | -$156K |
2022 Q2
16 quarters
|
|
1113
Oscar Health
OSCR
$10.5B
| $12.2M | ﹤0.01% |
429,180
+22,789
| +6% | +$491K |
2021 Q4
18 quarters
|
|
1114
JPMorgan Active Growth ETF
JGRO
$10.2B
| $12.2M | ﹤0.01% |
124,022
| – | – |
2026 Q1
1 quarter
|
|
1115
Ingevity
NGVT
$2.4B
| $12.2M | ﹤0.01% |
163,469
+5,848
| +4% | +$421K |
2016 Q2
40 quarters
|
|
1116
TXNM Energy Inc
TXNM
$6.44B
| $12.2M | ﹤0.01% |
214,209
-3,461
| -2% | -$203K |
2013 Q2
52 quarters
|
|
1117
Praxis Precision Medicines
PRAX
$7.14B
| $12.1M | ﹤0.01% |
36,187
-1,958
| -5% | -$620K |
2024 Q2
8 quarters
|
|
1118
British American Tobacco
BTI
$119B
| $12.1M | ﹤0.01% |
195,916
-11,153
| -5% | -$673K |
2025 Q3
3 quarters
|
|
1119
Versant Media Group
VSNT
$4.29B
| $12.1M | ﹤0.01% |
335,749
-21,544
| -6% | -$865K |
2026 Q1
1 quarter
|
|
1120
NETSTREIT Corp
NTST
$1.77B
| $12.1M | ﹤0.01% |
570,774
+24,274
| +4% | +$492K |
2023 Q1
13 quarters
|
|
1121
Merit Medical Systems
MMSI
$5.31B
| $12.1M | ﹤0.01% |
173,854
+18,276
| +12% | +$1.21M |
2023 Q1
13 quarters
|
|
1122
iShares Russell 1000 Value ETF
IWD
$83.2B
| $12M | ﹤0.01% |
49,697
-15,303
| -24% | -$3.56M |
2025 Q4
2 quarters
|
|
1123
NatWest
NWG
$68.3B
| $12M | ﹤0.01% |
682,776
-362
| -0.1% | -$5.82K |
2025 Q3
3 quarters
|
|
1124
Pathward Financial
CASH
$1.5B
| $12M | ﹤0.01% |
138,067
-17,220
| -11% | -$1.49M |
2023 Q1
13 quarters
|
|
1125
U.S. High Relative Profitability Portfolio ETF Class Shares
DUHP
$12.9B
| $12M | ﹤0.01% |
287,882
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.